HealthEquity, Inc. (NASDAQ:HQY) has been assigned an average rating of “Buy” from the eleven ratings firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $57.00.
Several equities research analysts recently issued reports on HQY shares. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 price objective on shares of HealthEquity in a research note on Tuesday, August 29th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $61.00 price objective (up from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Chardan Capital increased their price objective on HealthEquity from $53.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday, June 7th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research note on Wednesday, July 12th. Finally, BidaskClub downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th.
In other HealthEquity news, VP Jon Soldan sold 25,000 shares of the company’s stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $40.68, for a total value of $1,017,000.00. Following the transaction, the vice president now directly owns 30,652 shares of the company’s stock, valued at approximately $1,246,923.36. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Frank Medici sold 23,649 shares of the company’s stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $50.27, for a total value of $1,188,835.23. Following the completion of the transaction, the director now directly owns 6,381 shares in the company, valued at $320,772.87. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,676,034 shares of company stock worth $85,025,200. Insiders own 19.00% of the company’s stock.
A number of hedge funds have recently modified their holdings of HQY. BlackRock Inc. increased its holdings in shares of HealthEquity by 157,852.9% during the 1st quarter. BlackRock Inc. now owns 5,589,953 shares of the company’s stock valued at $237,293,000 after acquiring an additional 5,586,414 shares during the last quarter. Janus Henderson Group PLC increased its holdings in shares of HealthEquity by 627.9% during the 2nd quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock valued at $105,292,000 after acquiring an additional 1,822,732 shares during the last quarter. FMR LLC increased its holdings in shares of HealthEquity by 45.6% during the 2nd quarter. FMR LLC now owns 2,235,150 shares of the company’s stock valued at $111,378,000 after acquiring an additional 699,728 shares during the last quarter. TimesSquare Capital Management LLC acquired a new position in shares of HealthEquity during the 2nd quarter valued at about $25,822,000. Finally, Bank of New York Mellon Corp increased its holdings in shares of HealthEquity by 47.9% during the 1st quarter. Bank of New York Mellon Corp now owns 816,504 shares of the company’s stock valued at $34,661,000 after acquiring an additional 264,604 shares during the last quarter. 90.97% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/20/healthequity-inc-hqy-given-average-rating-of-buy-by-analysts.html.
Shares of HealthEquity (NASDAQ:HQY) opened at 47.38 on Wednesday. The firm has a 50-day moving average price of $44.62 and a 200 day moving average price of $46.01. HealthEquity has a 12-month low of $30.34 and a 12-month high of $54.95. The stock has a market cap of $2.87 billion, a PE ratio of 70.30 and a beta of 1.75.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business’s revenue for the quarter was up 28.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.16 EPS. Equities research analysts predict that HealthEquity will post $0.71 EPS for the current fiscal year.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.